DOCSLIB.ORG

Vectors and Vector Borne Diseases Annual Review of the Literature and Horizon Scanning Report 2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vectors and Vector Borne Diseases Annual Review of the Literature and Horizon Scanning Report 2019 Parasitology group: Vectors and vector borne diseases Annual review of the literature and horizon scanning report 2019 August 2020 © Crown copyright 2020 This information is licensed under the Open Government Licence v3.0. To view this licence, visit www.nationalarchives.gov.uk/doc/open-government-licence/ This publication is available at www.gov.uk/government/publications Any enquiries regarding this publication should be sent to us at [email protected] Year of publication: 2020 www.gov.uk/defra Contents Expert Review ...................................................................................................................... 1 VECTORS - Ticks and arthropods ................................................................................... 1 Novel tick species UK ....................................................................................................... 1 Vector control strategies ................................................................................................... 1 Tick vaccines .................................................................................................................... 1 Research into new tick treatments ................................................................................... 2 Acaricide resistance research .......................................................................................... 2 Research into new insect treatments ............................................................................... 3 VECTOR BORNE DISEASE - Test and surveillance developments ................................ 3 Tick pathogen surveys in Europe ..................................................................................... 4 Tularemia ......................................................................................................................... 4 Borrelia ............................................................................................................................. 4 Human babesiosis ............................................................................................................ 4 Livestock vector-borne diseases ...................................................................................... 5 Babesia ............................................................................................................................ 5 Research into new Babesia treatments ............................................................................ 6 Babesia vaccines ............................................................................................................. 6 Bovine besnoitiosis .......................................................................................................... 6 Trypanosomes ................................................................................................................. 7 Wildlife vector-borne diseases ......................................................................................... 7 Wildlife Anaplasma ........................................................................................................... 8 Wildlife Babesia ................................................................................................................ 8 Wildlife Borrelia ................................................................................................................ 8 Wildlife Theileria ............................................................................................................... 9 Bird blood parasites.......................................................................................................... 9 Tick borne encephalitis (TBE) virus .................................................................................. 9 Bluetongue virus .............................................................................................................. 9 Crimean-Congo Haemorrhagic Fever Virus (CCHFV)...................................................... 9 Rift valley fever virus and phleboviruses ........................................................................ 10 Other arboviruses ........................................................................................................... 10 Filarial worms ................................................................................................................. 11 Equine piroplasms .......................................................................................................... 11 Equine Trypanosomosis ................................................................................................. 11 Domestic pet vector-borne diseases .............................................................................. 12 Hepatozoon .................................................................................................................... 12 Canine Babesia .............................................................................................................. 12 Leishmania ..................................................................................................................... 13 Dirofilaria (Heart worm) .................................................................................................. 13 Schistosomes ................................................................................................................. 13 Abstracts ............................................................................................................................ 14 VECTORS - ticks and arthropods .................................................................................. 14 Vector control strategies ................................................................................................. 15 Tick vaccines .................................................................................................................. 16 Research into new tick treatments ................................................................................. 17 Acaricide resistance research ........................................................................................ 18 Research into new insect treatments ............................................................................. 18 VECTOR BORNE DISEASE - Test and surveillance developments .............................. 19 Tick pathogen surveys in Europe ................................................................................... 21 Tularemia ....................................................................................................................... 23 Borrelia ........................................................................................................................... 23 Human Babesiosis ......................................................................................................... 24 Livestock vector-borne diseases .................................................................................... 25 Babesia .......................................................................................................................... 28 Vectors of Babesiosis ..................................................................................................... 31 Research into new Babesia treatments .......................................................................... 31 Babesia vaccines ........................................................................................................... 33 Bovine besnoitiosis ........................................................................................................ 34 Trypanosomes ............................................................................................................... 38 Wildlife vector-borne diseases ....................................................................................... 39 Wildlife Anaplasma ......................................................................................................... 39 Wildlife Babesia .............................................................................................................. 41 Wildlife Borrelia .............................................................................................................. 41 Wildlife Theileria ............................................................................................................. 42 Bird blood parasites........................................................................................................ 43 Arboviruses (viruses transmitted by mosquitoes, ticks, or other arthropods) ..................... 43 Tick borne encephalitis (TBE) virus ................................................................................ 43 Bluetongue Virus ............................................................................................................ 44 Crimean-Congo Haemorrhagic Fever Virus (CCHFV).................................................... 45 Rift valley fever virus and phleboviruses ........................................................................ 48 Other arboviruses ........................................................................................................... 49 Filarial worms ................................................................................................................. 51 Equine piroplasmas ........................................................................................................ 51 Equine Trypanosomosis ................................................................................................
Load more

Recommended publications
  • Chorioméningite Lymphocytaire, Tuberculose, Échinococcose…
    LES ZOONOSES INFECTIEUSES Juin 2021 Ce document vous est offert par Boehringer Ingelheim Ce fascicule fait partie de l’ensemble des documents polycopiés rédigés de manière concertée par des enseignants de maladies contagieuses des quatre Ecoles nationales vétérinaires françaises, à l’usage des étudiants vétérinaires. Sa rédaction et sa mise à jour régulière ont été sous la responsabilité de B. Toma jusqu’en 2006, avec la contribution, pour les mises à jour, de : G. André-Fontaine, M. Artois, J.C. Augustin, S. Bastian, J.J. Bénet, O. Cerf, B. Dufour, M. Eloit, N. Haddad, A. Lacheretz, D.P. Picavet, M. Prave La mise à jour est réalisée depuis 2007 par N. Haddad La citation bibliographique de ce fascicule doit être faite de la manière suivante : Haddad N. et al. Les zoonoses infectieuses, Polycopié des Unités de maladies réglementées des Ecoles vétérinaires françaises, Boehringer Ingelheim (Lyon), juin 2021, 217 p. Nous remercions Boehringer Ingelheim qui, depuis de nombreuses années, finance et assure la réalisation de ce polycopié. * 1 2 OBJECTIFS D’APPRENTISSAGE Rang A (libellé souligné) et rang B A l’issue de cet enseignement, les étudiants devront être capables : • de répondre à des questions posées par une personne (propriétaire d'animaux, médecin...) relatives à la nature des principales maladies bactériennes et virales transmissibles à l'Homme lors de morsure par un carnivore . • de répondre à des questions posées par une personne (propriétaire d'animaux, médecin...) relatives à l'évolution de la maladie chez l'Homme, les modalités de la transmission et de la prévention des principales maladies bactériennes et virales transmissibles à l'Homme à partir des carnivores domestiques et les grandes lignes de leur prophylaxie.
    [Show full text]
  • Diapositiva 1
    Simultaneous outbreak of Dengue and Chikungunya in Al Hodayda, Yemen (epidemiological and phylogenetic findings) Giovanni Rezza1, Gamal El-Sawaf2, Giovanni Faggioni3, Fenicia Vescio1, Ranya Al Ameri4, Riccardo De Santis3, Ghada Helaly2, Alice Pomponi3, Alessandra Lo Presti1, Dalia Metwally2, Massimo Fantini5, FV, Hussein Qadi4, Massimo Ciccozzi1, Florigio Lista3 1Department of lnfectious, Parasitic and lmmunomediated Diseases, Istituto Superiore di Sanità, Roma, Italy; 2 Medical Research lnstitute- Alexandria University, Egypt; 3Histology and Molecular Biology Section, Army Medical an d Veterinary Research Center, Roma, ltaly; 4 University of Sana’a, Republic of Yemen; 5Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Roma, ltaly * * Background Fig.1 * * Yemen, which is located in the southwestern end of the Arabian Peninsula, is one of the * countries most affected by recurrent epidemics of dengue. * I We conducted a study on individuals hospitalized with dengue-like syndrome in Al Hodayda, with the aim of identifying viral agents responsible of febrile illness (i.e., dengue [DENV], chikungunya [CHIKV], Rift Valley [RVFV] and hemorrhagic fever virus Alkhurma). * * * Methods * The study site was represented by five hospital centers located in Al-Hodayda, United Republic * of Yemen. Patients were recruited in 2011 and 2012. Serum samples were analysed by ELISA * for the presence of IgM antibody against DENV and CHIKV by using commercial assays. Nucleic * acids were extracted by automated method and analyzed by using specific PCR for the Fig. 2 presence of sequences of DENV, RVF virus, Alkhurma virus and CHIKV. To confirm the results, 15 DENV positive sera underwent specific NS1 gene amplification and sequencing reaction. Similarly, CHIKV positive sera were thoroughly investigated by amplification and sequencing Conclusions the gene encoding the E1 protein.
    [Show full text]
  • Generic Amplification and Next Generation Sequencing Reveal
    Dinçer et al. Parasites & Vectors (2017) 10:335 DOI 10.1186/s13071-017-2279-1 RESEARCH Open Access Generic amplification and next generation sequencing reveal Crimean-Congo hemorrhagic fever virus AP92-like strain and distinct tick phleboviruses in Anatolia, Turkey Ender Dinçer1†, Annika Brinkmann2†, Olcay Hekimoğlu3, Sabri Hacıoğlu4, Katalin Földes4, Zeynep Karapınar5, Pelin Fatoş Polat6, Bekir Oğuz5, Özlem Orunç Kılınç7, Peter Hagedorn2, Nurdan Özer3, Aykut Özkul4, Andreas Nitsche2 and Koray Ergünay2,8* Abstract Background: Ticks are involved with the transmission of several viruses with significant health impact. As incidences of tick-borne viral infections are rising, several novel and divergent tick- associated viruses have recently been documented to exist and circulate worldwide. This study was performed as a cross-sectional screening for all major tick-borne viruses in several regions in Turkey. Next generation sequencing (NGS) was employed for virus genome characterization. Ticks were collected at 43 locations in 14 provinces across the Aegean, Thrace, Mediterranean, Black Sea, central, southern and eastern regions of Anatolia during 2014–2016. Following morphological identification, ticks were pooled and analysed via generic nucleic acid amplification of the viruses belonging to the genera Flavivirus, Nairovirus and Phlebovirus of the families Flaviviridae and Bunyaviridae, followed by sequencing and NGS in selected specimens. Results: A total of 814 specimens, comprising 13 tick species, were collected and evaluated in 187 pools. Nairovirus and phlebovirus assays were positive in 6 (3.2%) and 48 (25.6%) pools. All nairovirus sequences were closely-related to the Crimean-Congo hemorrhagic fever virus (CCHFV) strain AP92 and formed a phylogenetically distinct cluster among related strains.
    [Show full text]
  • Detection and Partial Molecular Characterization of Rickettsia and Bartonella from Southern African Bat Species
    Detection and partial molecular characterization of Rickettsia and Bartonella from southern African bat species by Tjale Mabotse Augustine (29685690) Submitted in partial fulfillment of the requirements for the degree MAGISTER SCIENTIAE (MICROBIOLOGY) in the Department of Microbiology and Plant Pathology Faculty of Natural and Agricultural Sciences University of Pretoria Pretoria, South Africa Supervisor: Dr Wanda Markotter Co-supervisors: Prof Louis H. Nel Dr Jacqueline Weyer May, 2012 I declare that the thesis, which I hereby submit for the degree MSc (Microbiology) at the University of Pretoria, South Africa, is my own work and has not been submitted by me for a degree at another university ________________________________ Tjale Mabotse Augustine i Acknowledgements I would like send my sincere gratitude to the following people: Dr Wanda Markotter (University of Pretoria), Dr Jacqueline Weyer (National Institute for Communicable Diseases-National Health Laboratory Service) and Prof Louis H Nel (University of Pretoria) for their supervision and guidance during the project. Dr Jacqueline Weyer (Centre for Zoonotic and Emerging diseases (Previously Special Pathogens Unit), National Institute for Communicable Diseases (National Heath Laboratory Service), for providing the positive control DNA for Rickettsia and Dr Jenny Rossouw (Special Bacterial Pathogens Reference Unit, National Institute for Communicable Diseases-National Health Laboratory Service), for providing the positive control DNA for Bartonella. Dr Teresa Kearney (Ditsong Museum of Natural Science), Gauteng and Northern Region Bat Interest Group, Kwa-Zulu Natal Bat Interest Group, Prof Ara Monadjem (University of Swaziland), Werner Marias (University of Johannesburg), Dr Francois du Rand (University of Johannesburg) and Prof David Jacobs (University of Cape Town) for collection of blood samples.
    [Show full text]
  • Potential Arbovirus Emergence and Implications for the United Kingdom Ernest Andrew Gould,* Stephen Higgs,† Alan Buckley,* and Tamara Sergeevna Gritsun*
    Potential Arbovirus Emergence and Implications for the United Kingdom Ernest Andrew Gould,* Stephen Higgs,† Alan Buckley,* and Tamara Sergeevna Gritsun* Arboviruses have evolved a number of strategies to Chikungunya virus and in the family Bunyaviridae, sand- survive environmental challenges. This review examines fly fever Naples virus (often referred to as Toscana virus), the factors that may determine arbovirus emergence, pro- sandfly fever Sicilian virus, Crimean-Congo hemorrhagic vides examples of arboviruses that have emerged into new fever virus (CCHFV), Inkoo virus, and Tahyna virus, habitats, reviews the arbovirus situation in western Europe which is widespread throughout Europe. Rift Valley fever in detail, discusses potential arthropod vectors, and attempts to predict the risk for arbovirus emergence in the virus (RVFV) and Nairobi sheep disease virus (NSDV) United Kingdom. We conclude that climate change is prob- could be introduced to Europe from Africa through animal ably the most important requirement for the emergence of transportation. Finally, the family Reoviridae contains a arthropodborne diseases such as dengue fever, yellow variety of animal arbovirus pathogens, including blue- fever, Rift Valley fever, Japanese encephalitis, Crimean- tongue virus and African horse sickness virus, both known Congo hemorrhagic fever, bluetongue, and African horse to be circulating in Europe. This review considers whether sickness in the United Kingdom. While other arboviruses, any of these pathogenic arboviruses are likely to emerge such as West Nile virus, Sindbis virus, Tahyna virus, and and cause disease in the United Kingdom in the foresee- Louping ill virus, apparently circulate in the United able future. Kingdom, they do not appear to present an imminent threat to humans or animals.
    [Show full text]
  • Human Case of Bartonella Alsatica Lymphadenitis
    LETTERS (6). The sequence is distinct from a DOI: 10.3201/eid1412.080944 Human Case of small number of sequences derived from rabies viruses in Vietnam, which References Bartonella alsatica suggests that China is a stronger can- Lymphadenitis 1. Smith JS, Fishbein DB, Rupprecht CE, didate for the source of the virus than Clark K. Unexplained rabies in three To the Editor: Lymph node en- her native country. immigrants in the United States: a vi- Although the case history could rologic investigation. N Engl J Med. largement is a common medical prob- not provide evidence for interaction 1991;324:205–11. lem that is usually caused by bacterial, 2. Grattan-Smith PJ, O’Regan WJ, Ellis PS, with a dog while her family was in viral, fungal, or protozoal agents (1). O’Flaherty SJ, McIntyre PB, Barnes CJ. A Malignancies or lymphoproliferative Hong Kong Special Administrative second Australian case, with a long incuba- Region, rabies was endemic within tion period. Med J Aust. 1992;156:651–4. diseases are often found, especially in the colony at the time that the pa- 3. McColl KA, Gould AR, Selleck PW, elderly patients (1). Bartonella hense- Hooper PT, Westbury HA, Smith JS. tient’s family was resident. From 1980 lae, the main causative agent of cat- Polymerase chain reaction and other labo- scratch disease (CSD), appears to be through 1984, 5 human cases were re- ratory techniques in the diagnosis of long corded (9). Only 2 case-patients had incubation rabies in Australia. Aust Vet the most common organism respon- clear evidence of a dog bite; histories J.
    [Show full text]
  • Alkhurma Hemorrhagic Fever in Humans, Najran, Saudi Arabia Abdullah G
    RESEARCH Alkhurma Hemorrhagic Fever in Humans, Najran, Saudi Arabia Abdullah G. Alzahrani, Hassan M. Al Shaiban, Mohammad A. Al Mazroa, Osama Al-Hayani, Adam MacNeil, Pierre E. Rollin, and Ziad A. Memish Alkhurma virus is a fl avivirus, discovered in 1994 in a district, south of Jeddah (3). Among the 20 patients with person who died of hemorrhagic fever after slaughtering a confi rmed cases, 11 had hemorrhagic manifestations and sheep from the city of Alkhurma, Saudi Arabia. Since then, 5 died. several cases of Alkhurma hemorrhagic fever (ALKHF), Full genome sequencing has indicated that ALKV is with fatality rates up to 25%, have been documented. From a distinct variant of Kyasanur Forest disease virus, a vi- January 1, 2006, through April 1, 2009, active disease sur- rus endemic to the state of Karnataka, India (4). Recently, veillance and serologic testing of household contacts identi- fi ed ALKHF in 28 persons in Najran, Saudi Arabia. For epi- ALKV was found by reverse transcription–PCR in Orni- demiologic comparison, serologic testing of household and thodoros savignyi ticks collected from camels and camel neighborhood controls identifi ed 65 serologically negative resting places in 3 locations in western Saudi Arabia (5). persons. Among ALKHF patients, 11 were hospitalized and ALKHF is thought to be a zoonotic disease, and reservoir 17 had subclinical infection. Univariate analysis indicated hosts may include camels and sheep. Suggested routes of that the following were associated with Alkhurma virus in- transmission are contamination of a skin wound with blood fection: contact with domestic animals, feeding and slaugh- of an infected vertebrate, bite of an infected tick, or drink- tering animals, handling raw meat products, drinking unpas- ing of unpasteurized, contaminated milk (6).
    [Show full text]
  • Alkhurma Hemorrhagic Fever Virus March 25 Th, 2009
    Department of International & Tropical diseases Alkhurma Hemorrhagic Fever Virus March 25th, 2009 1. ALKHURMA HEMORRHAGIC FEVER • Seasonality: Unknown. Seasonality not excluded VIRUS (AHFV) (see figure 1). To date, available data are insufficient to document it. • Isolated for the first time in 1994 in Alkhumra district (south of Jeddah), Makkah province, Saudi Arabia. Figure 1. Annual distribution of 11 AHFV infections in Saudi Arabia, 1994–1999 (Charrel, Zaki et al., 2005) • Genus: Flavivirus. Genetically very closely related to Kyasanur forest disease (KFD) virus, which circulates in India (Karnataka) and probably in China. • Vector: Ticks, (possible other vectors) Available data are in favour of ticks bite transmission: ° AHFV is genetically and serologically closely related to tick-borne flaviviruses. ° Tick bite has been associated with clinical cases. ° AHFV RNA was recently detected in ticks (Ornithodoros savignyi) collected on a camel resting place in Jeddah. ° O. savignyi were found where AHFV infected cases were reported. The hypothesis that mosquitoes could also be vectors was mentioned in a prospective survey performed in • Incubation period: Unknown. Probably similar to Saudi Arabia. Although this hypothesis cannot be KFD, i.e. 3-8 days. formally excluded, no data were provided to • Clinic: Acute febrile flulike illness with hepatitis substantiate it. (100%), hemorrhagic manifestations (55%), and • Reservoir: Not documented. Probably sheep, camels, encephalitis (20%). The potential existence of pauci- goats. symptomatic and asymptomatic forms is unknown but probable. • Geographical distribution: Unknown. Reported only in Saudi Arabia in Makkah and Najran provinces, both • Lethality: 25-30% of reported cases. located on West coast of the country (Map 1). • Diagnostic: PCR, viral culture and serology (possible Map 1.
    [Show full text]
  • Human Bartonellosis: an Underappreciated Public Health Problem?
    Tropical Medicine and Infectious Disease Review Human Bartonellosis: An Underappreciated Public Health Problem? Mercedes A. Cheslock and Monica E. Embers * Division of Immunology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, LA 70433, USA; [email protected] * Correspondence: [email protected]; Tel.: +(985)-871-6607 Received: 24 March 2019; Accepted: 16 April 2019; Published: 19 April 2019 Abstract: Bartonella spp. bacteria can be found around the globe and are the causative agents of multiple human diseases. The most well-known infection is called cat-scratch disease, which causes mild lymphadenopathy and fever. As our knowledge of these bacteria grows, new presentations of the disease have been recognized, with serious manifestations. Not only has more severe disease been associated with these bacteria but also Bartonella species have been discovered in a wide range of mammals, and the pathogens’ DNA can be found in multiple vectors. This review will focus on some common mammalian reservoirs as well as the suspected vectors in relation to the disease transmission and prevalence. Understanding the complex interactions between these bacteria, their vectors, and their reservoirs, as well as the breadth of infection by Bartonella around the world will help to assess the impact of Bartonellosis on public health. Keywords: Bartonella; vector; bartonellosis; ticks; fleas; domestic animals; human 1. Introduction Several Bartonella spp. have been linked to emerging and reemerging human diseases (Table1)[ 1–5]. These fastidious, gram-negative bacteria cause the clinically complex disease known as Bartonellosis. Historically, the most common causative agents for human disease have been Bartonella bacilliformis, Bartonella quintana, and Bartonella henselae.
    [Show full text]
  • Veterinary Parasitology
    Andrei Daniel MIHALCA Textbook of Veterinary Parasitology Introduction to parasitology. Protozoology. AcademicPres Andrei D. MIHALCA TEXTBOOK OF VETERINARY PARASITOLOGY Introduction to parasitology Protozoology AcademicPres Cluj-Napoca, 2013 © Copyright 2013 Toate drepturile rezervate. Nici o parte din această lucrare nu poate fi reprodusă sub nici o formă, prin nici un mijloc mecanic sau electronic, sau stocată într-o bază de date, fără acordul prealabil, în scris, al editurii. Descrierea CIP a Bibliotecii Naţionale a României Mihalca Andrei Daniel Textbook of Veterinary Parasitology: Introduction to parasitology; Protozoology / Andrei Daniel Mihalca. Cluj-Napoca: AcademicPres, 2013 Bibliogr. Index ISBN 978-973-744-312-0 339.138 Director editură – Prof. dr. Carmen SOCACIU Referenţi ştiinţifici: Prof. Dr. Vasile COZMA Conf. Dr. Călin GHERMAN Editura AcademicPres Universitatea de Ştiinţe Agricole şi Medicină Veterinară Cluj-Napoca Calea Mănăştur, nr. 3-5, 400372 Cluj-Napoca Tel. 0264-596384 Fax. 0264-593792 E-mail: [email protected] Table of contents 1 INTRODUCTION TO PARASITOLOGY ..................................................................................... 1 1.1 DEFINING PARASITOLOGY. DIVERSITY OF PARASITISM IN NATURE. ................................................. 1 1.2 PARASITISM AS AN INTERSPECIFIC INTERACTION ............................................................................... 2 1.3 AN ECOLOGICAL APPROACH TO PARASITOLOGY ................................................................................... 5 1.4
    [Show full text]
  • Ru 2015 150 263 a (51) Мпк A61k 31/155 (2006.01)
    РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) (11) (13) RU 2015 150 263 A (51) МПК A61K 31/155 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка: 2015150263, 01.05.2014 (71) Заявитель(и): НЕОКУЛИ ПТИ ЛТД (AU) Приоритет(ы): (30) Конвенционный приоритет: (72) Автор(ы): 01.05.2013 AU 2013901517 ПЕЙДЖ Стефен (AU), ГАРГ Санджай (AU) (43) Дата публикации заявки: 06.06.2017 Бюл. № 16 RU (85) Дата начала рассмотрения заявки PCT на национальной фазе: 01.12.2015 (86) Заявка PCT: AU 2014/000480 (01.05.2014) 2015150263 (87) Публикация заявки PCT: WO 2014/176634 (06.11.2014) Адрес для переписки: 190000, Санкт-Петербург, Box-1125, "ПАТЕНТИКА" A (54) СПОСОБЫ ЛЕЧЕНИЯ БАКТЕРИАЛЬНЫХ ИНФЕКЦИЙ (57) Формула изобретения 1. Способ лечения или профилактики бактериальной колонизации или инфекции у субъекта, включающий стадию: введения субъекту терапевтически эффективного количества робенидина или его терапевтически приемлемой соли, причем указанная A бактериальная колонизация или инфекция вызвана бактериальным агентом. 2. Способ по п. 1, отличающийся тем, что субъект выбран из группы, включающей: человека, животных, принадлежащих видам семейства псовых, кошачьих, крупного рогатого скота, овец, коз, свиней, птиц, рыб и лошадей. 3. Способ по п. 1, отличающийся тем, что робенидин вводят субъекту в дозе в диапазоне от 0,1 до 250 мг/кг массы тела. 4. Способ по любому из пп. 1-3, отличающийся тем, что бактериальный агент является 2015150263 грамположительным. 5. Способ по п. 4, отличающийся тем, что бактериальный агент выбран из
    [Show full text]
  • The-Dictionary-Of-Virology-4Th-Mahy
    The Dictionary of VIROLOGY This page intentionally left blank The Dictionary of VIROLOGY Fourth Edition Brian W.J. Mahy Division of Emerging Infections and Surveillance Services Centers for Disease Control and Prevention Atlanta, GA 30333 USA AMSTERDAM • BOSTON • HEIDELBERG • LONDON • NEW YORK • OXFORD PARIS • SAN DIEGO • SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA 525 B Street, Suite 1900, San Diego, California 92101-4495, USA 32 Jamestown Road, London NW1 7BY, UK Copyright © 2009 Elsevier Ltd. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or trans- mitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Departmentin Oxford, UK: phone (ϩ44) (0) 1865 843830; fax (ϩ44) (0) 1865 853333; email: [email protected]. Alternatively visit the Science and Technology website at www.elsevierdirect.com/rights for further information Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Library of Congress Cataloguing in Publication Data A catalogue record for this book is available from the Library of Congress ISBN 978-0-12-373732-8 For information on all Academic Press publications visit our website at www.elsevierdirect.com Typeset by Charon Tec Ltd., A Macmillan Company.
    [Show full text]